• Tetrahedral DNA Frameworks Enhance Enzymatic Oligonucleotide

  2026-05-28

  This study introduces a 3D DNA nanostructure-based interface to address enzyme accessibility challenges in enzymatic oligonucleotide synthesis (EOS). By employing highly ordered tetrahedral DNA nanostructures (TDN), the researchers achieved higher fidelity, reduced deletion errors, and efficient synthesis of long DNA fragments, with significant implications for DNA storage and advanced molecular applications.

• BH3 Mimetics Clear Chemotherapy-Induced Senescence in TP53 W

  2026-05-27

  The reference study demonstrates that BH3 mimetics targeting BCL-XL selectively eliminate chemotherapy-induced senescent cells in TP53 wild-type breast cancer models, improving tumor regression and survival outcomes. This mechanistic insight highlights the therapeutic potential of BCL-XL inhibition for overcoming residual disease after chemotherapy.

• MEK1/2 and c-Myc:MAX Prevent Polycomb Repression of TERT in

  2026-05-27

  This study uncovers a cooperative mechanism by which MEK1/2 kinases and the c-Myc:MAX complex maintain telomerase (TERT) expression in human pluripotent stem cells by limiting polycomb-mediated repression at the promoter. The findings clarify how MAPK signaling and transcription factor dimerization integrate to regulate telomere protection, with implications for stem cell biology and telomere-related diseases.

• Genistein: Applied Protocols for Cytoskeleton-Driven Cancer

  2026-05-26

  Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) empowers researchers to dissect tyrosine kinase signaling and cytoskeleton-mediated autophagy in cancer biology. This guide translates bench findings and recent mechanotransduction insights into robust, reproducible workflows using APExBIO’s high-purity Genistein.

• STUB1-TPIT Axis Modulates ACTH Secretion in Cushing Disease

  2026-05-26

  Liu et al. reveal that the E3 ubiquitin ligase STUB1 targets the transcription factor TPIT for proteasomal degradation, thereby suppressing pro-opiomelanocortin (POMC) transcription and ACTH secretion in Cushing disease. These findings establish STUB1 as a potential therapeutic target and provide mechanistic insight into ACTH regulation in pituitary corticotroph adenomas.

• ATS-9R: Precision Gene Silencing in Adipocytes for Metabolic

  2026-05-25

  ATS-9R (Adipocyte-targeting sequence-9-arginine) redefines non-viral gene delivery by enabling highly specific, efficient, and low-toxicity gene silencing in white adipose tissue. Its Prohibitin-mediated targeting and robust nucleic acid condensation open new avenues for obesity, insulin resistance, and metabolic syndrome research.

• Genistein (A2198): Selective Tyrosine Kinase Inhibitor Facts

  2026-05-25

  Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) is a well-characterized selective tyrosine kinase inhibitor with established roles in cell proliferation inhibition and cancer chemoprevention. Its biochemical benchmarks and mechanism are supported by quantitative in vitro and in vivo data. This article details protocol parameters, evidence, and key limitations for translational research.

• EPZ5676 DOT1L Inhibitor: Optimizing H3K79 Methylation Assays

  2026-05-24

  EPZ5676 stands out as a best-in-class DOT1L inhibitor, enabling researchers to precisely dissect H3K79 methylation and MLL-rearranged leukemia pathways with unmatched selectivity. This guide details robust workflows, troubleshooting strategies, and practical insights that set EPZ5676 apart for translational epigenetics research.

• CA-074: Cathepsin B Inhibitor Workflows for Necroptosis & Me

  2026-05-23

  Unlock the full potential of CA-074, a selective cathepsin B inhibitor, in dissecting necroptosis and cancer metastasis pathways. This guide delivers advanced experimental workflows, actionable troubleshooting, and key insights from the latest mechanistic breakthroughs.

• FerroOrange Fe²⁺ Indicator: Live-Cell Iron Detection & Evide

  2026-05-22

  FerroOrange is a selective Fe²⁺ fluorescent probe for live-cell intracellular iron detection. It enables quantitative tracking of ferrous ions in real time, supporting research into iron metabolism and ferroptosis with high specificity and reproducibility.

• Reserpine (N1867): Technical Guidance for Neuropharmacology

  2026-05-22

  Reserpine (SKU N1867) is a bioactive natural product used to model neurotransmitter depletion and study antihypertensive mechanisms in controlled research settings. This compound is not suitable for diagnostic or medical use and requires careful protocol adherence to maintain experimental consistency.

• Nitrocefin: Precision in β-Lactamase Detection and Resistanc

  2026-05-21

  This thought-leadership article explores the mechanistic, experimental, and translational significance of Nitrocefin as a chromogenic cephalosporin substrate. Integrating recent discoveries on multidrug-resistant pathogens, it offers actionable guidance for translational researchers confronting the urgent challenge of β-lactam antibiotic resistance.

• Nitrocefin in β-Lactamase Research: Kinetic Precision and Em

  2026-05-21

  Explore the advanced use of Nitrocefin as a chromogenic cephalosporin substrate for precise β-lactamase activity measurement. This in-depth analysis reveals how kinetic profiling with Nitrocefin enhances resistance research and informs the next generation of clinical microbiology assays.

• Tin Mesoporphyrin IX: Optimizing Heme Oxygenase Activity Ass

  2026-05-20

  Tin Mesoporphyrin IX (chloride) is transforming metabolic and virology research by enabling precise, high-affinity inhibition of heme oxygenase. This guide details actionable workflows, troubleshooting strategies, and key insights from recent HBV research that empower scientists to design robust, reproducible assays.

• Vacuolin-1: A Lysosomal Exocytosis Inhibitor for Precision C

  2026-05-20

  Vacuolin-1 offers selective, robust inhibition of Ca2+-dependent lysosomal exocytosis, empowering researchers to dissect membrane repair and trafficking pathways with quantitative precision. This guide bridges recent discoveries in cartilage pathology and lysosomal storage disorders with actionable experimental workflows and troubleshooting insights for maximizing Vacuolin-1’s research impact.

467 records 11/32 page Previous Next First page 上5页 1112131415 下5页 Last page